Patrick Mayes

Title: Patrick Mayes - Innovator in PD-1 Binding Domains

Introduction

Patrick Mayes is an accomplished inventor based in Wilmington, DE (US). He is known for his significant contributions to the field of immunology, particularly through his innovative work on PD-1 binding domains. His research focuses on enhancing the efficacy of treatments for diseases associated with a suppressed immune system, such as cancer.

Latest Patents

Patrick Mayes holds 1 patent related to PD-1 binding domains. This patent discloses novel PD-1 binding domains that exhibit a higher binding affinity for human PD-1 compared to a reference PD-1 binding domain. The binding domains not only demonstrate comparable or superior potency in blocking ligand binding to human PD-1 but also include binding moieties that incorporate these domains. Furthermore, the patent outlines methods for treating diseases linked to a suppressed immune system, utilizing the PD-1 binding domains or binding moieties. It also covers nucleic acids encoding the heavy chain variable region of the PD-1 binding domains, along with vectors and cells containing such nucleic acids.

Career Highlights

Throughout his career, Patrick Mayes has worked with notable companies in the biotechnology sector, including Merus N.V. and Incyte Corporation. His experience in these organizations has contributed to his expertise in developing innovative therapeutic solutions.

Collaborations

Patrick has collaborated with esteemed colleagues such as Simon Edward Plyte and Horacio G Nastri. These partnerships have further enriched his research and development efforts in the field of immunology.

Conclusion

Patrick Mayes is a prominent inventor whose work on PD-1 binding domains has the potential to significantly impact cancer treatment and immunotherapy. His innovative approach and collaborations highlight his commitment to advancing medical science.